HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

S Brändlein Selected Research

Genomic Medicine

1/2022Treatment outcome of atypical EGFR mutations in the German National Network Genomic Medicine Lung Cancer (nNGM).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


S Brändlein Research Topics

Disease

4Neoplasms (Cancer)
12/2006 - 01/2001
4Carcinoma (Carcinomatosis)
02/2005 - 08/2001
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022
1Lung Neoplasms (Lung Cancer)
01/2022
1Neoplasm Metastasis (Metastasis)
02/2005
1Gastritis
02/2005
1Lymphatic Metastasis
02/2005
1Synovitis
12/2002
1Psoriatic Arthritis
12/2002
1Adenocarcinoma
11/2001

Drug/Important Bio-Agent (IBA)

4Immunoglobulin M (IgM)IBA
12/2006 - 08/2001
3AntibodiesIBA
12/2006 - 01/2004
2Chemokine ReceptorsIBA
02/2005 - 12/2003
2AntigensIBA
01/2005 - 12/2002
2SC-1 monoclonal antibodyIBA
11/2001 - 01/2001
1ErbB Receptors (EGF Receptor)IBA
01/2022
1Tyrosine Kinase InhibitorsIBA
01/2022
1CarbohydratesIBA
01/2005
1ChemokinesIBA
12/2003
1InterferonsIBA
12/2003
1Chemotactic FactorsIBA
12/2003
1CXC ChemokinesIBA
12/2003
1InterleukinsIBA
12/2003
1Immunoglobulins (Immunoglobulin)IBA
11/2001
1CD55 Antigens (Decay Accelerating Factor)IBA
11/2001
1Serine (L-Serine)FDA Link
01/2001
1Proteins (Proteins, Gene)FDA Link
01/2001
1Tyrosine (L-Tyrosine)FDA Link
01/2001

Therapy/Procedure

1Genomic Medicine
01/2022
1Therapeutics
12/2006